Further increase of vancomycin-resistant Enterococcus faecium, amikacin- and fluoroquinolone-resistant Klebsiella pneumoniae, and imipenem-resistant Acinetobacter spp. in Korea: 2003 KONSAR surveillance

Yonsei Medical Journal

Volumn 47, Issue 1, 2006, Pages 43-54

  Lee, Kyungwon ^a   Park, Ki Hyung ^b   Jeong, Seok Hoon ^c   Lim, Hwan Sub ^d   Shin, Jong Hee ^e   Yong, Dongeun ^a   Ha, Gyoung Yim ^f   Chong, Yunsop ^a   Kim, Jae Seok ^g   Kim, Sunjoo ^h   Ryoo, Namhee ⁱ   Kim, Mun Yeun ^j   Chang, Chulhun L ^k   Kim, Mi Na ^l   Lee, Wee Gyo ^m   Kim, Myungshin ⁿ   Lee, Chea Hoon ^o   Kim, Jeong Ho ^p   Jeong, Joseph ^q   Cho, Ji Hyun ^r   Uh, Young ^s   Hong, Ki Sook ^t   Shin, Bo Moon ^u   Lee, Hye Soo ^v   Jang, Sook Jin ^w   Park, Ae Ja ^x   Cha, Young Joo ^y   Choi, Young Jin ^z   Kang, Sung Ha ^g   Rhim, Chang Hyun ^aa   Lee, Myung Hee ^ab   Song, Wonkeun ^g   Choi, Tae Yeal ^ac   Kim, Eui Chong ^ad   Kang, Jung Oak ^ac   Park, Yeon Joon ^ae   Hong, Seong Geun ^af   Young, Ah Kim ^ag   Lee, Hee Joo ^ah   Lee, Jongwook ^ai   Lee, Young Joon ^aj   Lee, Miae ^ak   Shin, Hee Bong ^z   Kim, Young Ree ^al   Lee, Seung Ok ^am   Lee, Sung Hee ^an   more..

^a Yonsei University College of Medicine   (South Korea)

^b Busan Medical Center   (South Korea)

^c Kosin University   (South Korea)

^d Catholic Kwandong University   (South Korea)

^e Chonnam National University Medical School   (South Korea)

^f Dongguk University Gyeongju Hospital   (South Korea)

^g Hallym University   (South Korea)

^h Gyeongsang National University   (South Korea)

ⁱ Keimyung University   (South Korea)

^j Dankook University   (South Korea)

^k Pusan National University School of Medicine   (South Korea)

^l University of Ulsan   (South Korea)

^m Ajou University Medical Center   (South Korea)

ⁿ The Catholic University of Korea   (South Korea)

^o Young Nam University Hospital   (South Korea)

^p Yonsei University College of Medicine   (South Korea)

^q Ulsan University College of Medicine   (South Korea)

^r Wonkwang University Hospital   (South Korea)

^s Yonsei University Wonju   (South Korea)

^t Ewha Womans University   (South Korea)

^u Inje University College of Medicine   (South Korea)

^v Chonbuk National University Medical School   (South Korea)

^w Chosun University   (South Korea)

^x Chung Ang University   (South Korea)

^y Chung Ang University   (South Korea)

^z Soonchunhyang University College of Medicine   (South Korea)

^aa Wallace Memorial Baptist Hospital   (South Korea)

^ab Korea Veterans Hospital   (South Korea)

^ac Hanyang University   (South Korea)

^ad Seoul National University   (South Korea)

^ae The Catholic University of Korea   (South Korea)

^af CHA University   (South Korea)

^ag National Health Insurance Corporation   (South Korea)

^ah Kyung Hee University College of Medicine   (South Korea)

^ai Konyang University College of Medicine   (South Korea)

^aj National Cancer Center   (South Korea)

^ak Mokdong Hospital   (South Korea)

^al Jeju National University   (South Korea)

^am Seoul Clinical Laboratories   (South Korea)

^an Cheju Hanmaeum Hospital   (South Korea)

more..

Author keywords

Antimicrobial resistance surveillance; Fluoroquinolone resistance; Imipenem; Korea; Vancomycin resistance

Indexed keywords

AMIKACIN; AMPICILLIN; AZTREONAM; CEFALOTIN; CEFEPIME; CEFOTAXIME; CEFOTETAN; CEFOXITIN; CEFTAZIDIME; CEPHALOSPORIN; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; OXACILLIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLONE DERIVATIVE; SULPERAZON; SULTAMICILLIN; TEICOPLANIN; TETRACYCLINE; TIMENTIN; TOBRAMYCIN; UNINDEXED DRUG; VANCOMYCIN;

ACINETOBACTER; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM ISOLATION; DRUG SURVEILLANCE PROGRAM; ENTEROBACTER INFECTION; ENTEROCOCCAL INFECTION; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; KOREA; MULTIDRUG RESISTANCE; NONHUMAN; PREVALENCE; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; TERTIARY HEALTH CARE;

ACINETOBACTER; ACINETOBACTER INFECTIONS; AMIKACIN; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; ENTEROCOCCUS FAECIUM; FLUOROQUINOLONES; GAMMAPROTEOBACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; IMIPENEM; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; KOREA; MICROBIAL SENSITIVITY TESTS; POPULATION SURVEILLANCE; VANCOMYCIN; VANCOMYCIN RESISTANCE;

EID: 33644811340     PISSN: 05135796     EISSN: 05135796     Source Type: Journal    
DOI: 10.3349/ymj.2006.47.1.43     Document Type: Article

References (37)

1. Wise R. The relentless rise of resistance? J Antimicrob Chemother 2004;54:306-10.
2. Bax R, Bywater R, Cornaglia G, Goosens H, Hunter P, Isham V, et al. Surveillance of antimicrobial resistance-what, how and whither? Clin Microbiol Infect 2001;7: 316-25.
3. Morris AK, Masterton RG. Antibiotic resistance surveillance: action for international studies. J Antimicrob Chemother 2002;49:7-10.
4. Felmingham D, Grueneberg RN, Alexander Project group. The Alexander project 1996-1997: latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections. J Antimicrob Chemother 2000;45:191-203.
5. Van Beneden CA, Lexau C, Baughman W, Barnes B, Bennett N, Cassidy PM, et al. Aggregated antibiograms and monitoring of drug-resistant Streptococcus pneumoniae. Emerg Infect Dis 2003;9:1089-95.
6. Cornaglia G, Hryniewicz W, Jarlier V, Kahlmeter G, Mittermayer H, Stratchounski L, et al. European recommendations for antimicrobial resistance surveillance. Clin Microbiol Infect 2004;10:349-83.
7. Chong Y, Lee K, Park YJ, Jeon DS, Lee MH, Kim MY, et al. Korean nationwide surveillance of antimicrobial resistance of bacteria in 1997. Yonsei Med J 1998;39:569-77.
8. Lee K, Kim YA, Park YJ, Lee HS, Kim MY, Kim E-C, et al. Increasing prevalence of vancomyin-resistant enterococci, and cefoxitin-, imipenem- and fluorquinolone-resistant gram-negative bacilli; a KONSAR study in 2002. Yonsei Med J 2004;45:598-608.
9. Lee K, Lee WG, Uh Y, Ha GY, Cho J, Chong Y, et al. VIM- and IMP-type metallo-β-lactamase-producing Pseudomonas spp. and Acinetobacter spp. in Korean hospitals. Emerg Infect Dis 2003;9:868-71.
10. Lee K, Lee M, Shin JH, Lee MH, Kang SH, Park AJ, et al. 2004. Plasmid mediated ampC genes in cefoxitin-resistant E. coli and K. pneumoniae clinical isolates. Abstr. C2-1339. 44th Interscience Conference of Antimicrobial Agents and Chemotherapy, 2004, Washington, DC.
11. Urban C, Segal-Maurer S, Rahal JJ. Considerations in control and treatment of nosocomial infections due to multidrug-resistant Acinetobacter baumannii. Clin Infect Dis 2003;36:1268-74.
12. National Committee for Clinical Laboratory Standards. Analysis and presentation of cumulative antimicrobial susceptibility test data. Approved guideline M39-A. Wayne, PA: NCCLS, 2002.
13. Fridkin SK, Hill HA, Volova NV, Edwards JR, Lawton RM, Gaynes RP, et al. Intensive Care Antimicrobial Resistance Epidemiology (ICARE) Project Hospitals. Temporal changes in prevalence of antimicrobial resistance in 23 U.S. hospitals. Emerg Infect Dis 2002;8:697-701.
14. Stelling JM, O'Brien TF. Surveillance of antimicrobial resistance: the WHONET program. Clin Infect Dis 1997: 24:S157-68.
15. Sahm DF, Marsilio MK, Piazza G. Antimicrobial resistance in key bloodstream bacterial isolates: electronic surveillance with the Surveillance Network Database-USA. Clin Infect Dis. 1999;29:259-63.
16. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing: thirteen's informational supplement, Wayne, PA, NCCLS, 2003.
17. Pai H, Choi E-W, Lee H-J, Hong JY, Jacoby GA. Identification of CTX-M-14 extended-spectrum β-lactamase in clinical isolates of Shigella sonnei, Escherichia coli, and Klebsiella pneumoniae in Korea. J Clin Microbiol 2001;39:3747-9.
18. Bonnet R. Growing group of extended-spectrum β-lactamases: the CTX-M enzymes. Antimicrob Agents Chemother 2004;48:1-14.
19. Yasunaka K, Kono K. Epidemiological study of methicillin-resistant Staphylococcus aureus at Fukuoka University Hospital. Microb Drug Resist. 1999; 5:207-13.
20. Tiemersma EW, Bronzwaer SLAM, Lyytikainen O, Degener JE, Schrijnemakers P, Bruinsma N, et al. Methicillin-resistant Staphylococcus aureus in Europe, 1999-2002. Emerg Infect Dis 2004;10:1627-34.
21. Song J-H, Jung S-I, Ki HK, Shin M-H, Ko KS, Son JS, et al. Clinical outcomes of pneumococcal pneumonia caused by antibiotic-resistant strains in Asian countries: a study by the Asian Network for Surveillance of Resistant Pathogens. Clin Infect Dis 2004;38:1570-8.
22. Mera RM, Miller LA, Daniels JJD, Weil JG, White AR. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States over a 10-year period: Alexander Project. Diag Microbiol Infect Dis 2005;51:195-200.
23. Treitman AN, Yarnold PR, Warren J, Noskin GA. Emerging incidence of Enterococcus faecium among hospital isolates (1993 to 2002). J Clin Microbiol 2005,43: 462-3.
24. Lauderdale TL, McDonald LC, Shiau YR, Chen PC, Wang HY, Lai JF, et al. The status of antimicrobial resistance in Taiwan among gram-negative pathogens: the Taiwan surveillance of antimicrobial resistance (TSAR) program, 2000. Diag Microbiol Infect Dis 2004; 48:211-9.
25. Hasegawa K, Chiba N, Kobayashi R, Murayama Y, Iwata S, Sunakawa K, et al. Rapidly increasing prevalence of β-lactamase-nonproducing, ampicillin- resistant Haemophilus influenzae type b in patients with meningitis. Antimicrob Agents Chemother 2004;48: 1509-14.
26. Park M-S, Kang Y-H, Lee S-J, Song C-Y, Lee B-K. Characteristics of epidemic multidrug-resistant Salmonella enterica serovar Typhimurium DT104 strains first isolated in Korea. Korean J Infect Dis 2002;34:1-8.
27. Jeong SH, Bae IK, Lee JH, Sohn SG, Kang GH, Jeon GJ, et al. Molecular characterization of extended-spectrum beta-lactamases produced by clinical isolates of Klebsiella pneumoniae and Escherichia coli from a Korean Nationwide Survey. J Clin Microbiol 2004;42:2902-6.
28. Livermore DM, Woodford N. Carbapenemases: a problem in waiting? Curr Opin Microbiol. 2000;3:489-95.
29. Kim IS, Oh WI, Song JH, Lee NY. Screening and identification of metallo-β-lactamase gene in clinical isolates of imipenem-resistant Pseudomonas aeruginosa. Korean J Lab Med 2004;24:177-82.
30. Tsuji A, Kobayashi I, Oguri T, Inoue M, Yabuuchi F, Goto S. An epidemiological study of the susceptibility and frequency of multiple-drug-resistant strains of Pseudomonas aeruginosa isolated at medical institutes nationwide in Japan. J Infect Chemother 2005;11:64-70.
31. Jeong SH, Lee K, Chong Y, Yum JH, Lee SH, Choi HJ, et al. Characterization of a new integron containing VIM-2, a metallo-β-lactamase gene cassette, in a clinical isolate of Enterobacter cloacae. J Antimicrob Chemother 2003;51:397-400.
32. Hooper DC. The future of the quinolones. APUA Newsletter 2001;19:1-5.
33. Abbo A, Navon-Venezia S, Hammer-Muntz O, Krichali T, Siegman-Igra Y, Carmeli Y. Multidrug-resistant Acinetebacter baumannii. Emerg Infect Dis 2005;11:22-9.
34. Kuo LC, Teng LJ, Yu CJ, Ho SW, Hsueh PR. Dissemination of a clone of unusual phenotype of pandrug-resistant Acinetobacter baumannii at a university hospital in Taiwan. J Clin Microbiol 2004;42:1759-63.
35. Reis AO, Luz DAM, Tognim MCB, Sader HS, Cales AC. Polymyxin-resistant Acinetobacter spp. isolates; what is next? Emerg Infect Dis 2003;9:1025-7.
36. Critchley IA, Karlousky JA. Optimal use of antibiotic resistance surveillance systems. Clin Microbiol Infect 2004;10:502-11.
37. Lee S-O, Cho YK, Kim S-Y, Lee ES, Park SY, Soo Y-H. Comparison of trends of resistance rates over 3 years calculated from results for all isolates and for the first isolate of a given species from a patient. J Clin Microbiol 2004;42:4776-9.